Prostate Cancer Journal Articles

• Risk of Hepatic and Extrahepatic Cancer in NAFLD This study investigated the risk of hepatic and extrahepatic cancer in patients with NAFLD compared to the general population.
  Liver International, May 16, 2022
• Efficacy and Safety of Dutasteride and Finasteride in BPH Are these two drugs safe and effective options for the treatment of benign prostatic hyperplasia?
  Translational Andrology and Urology, May 11, 2022
• Metformin and the Risk of Prostate Cancer in Diabetic Men Is there an association between metformin therapy and prostate cancer risk? This study aimed to clarify apparent conflicting evidence of prior studies.
  American Journal of Epidemiology, May 05, 2022
• COVID-19 Pandemic Impacts on Treatment for Metastatic Cancer The COVID-19 pandemic has resulted in delays and disruptions in health care. Has it similarly affected the treatment of patients with metastatic cancer?
  Journal of the National Cancer Institute, May 04, 2022
• PDE5 Inhibitors for ED After Radical Prostatectomy Erectile dysfunction is a known complication of nerve-sparing radical prostatectomy. Could postoperative PDE5 inhibitor treatment help?
  Translational Andrology and Urology, March 31, 2022
• Characteristics, Comorbidities and Testosterone Prescribing Certain factors may impact the decision of whether or not to prescribe testosterone replacement therapy. What are they?
  Clinical Endocrinology, March 24, 2022
• Cancer Survivorship and Subclinical Myocardial Damage What is the potential clinical significance of elevated high-sensitivity cardiac troponin T in cancer survivors?
  American Journal of Epidemiology, March 23, 2022
• Tranexamic Acid for the Prevention of Surgical Bleeding Learn more about the role of tranexamic acid in preventing bleeding in soft-tissue surgery.
  Plastic and Reconstructive Surgery, March 22, 2022
• Simplifying Survivorship Care Planning Which of these survivorship care plan delivery approaches is the simplest and most effective?
  Journal of the National Cancer Institute, February 23, 2022
• The Adverse Impact of COVID-19 on Men's Health In what ways could COVID-19 infection adversely affect the male genitourinary system and men's overall health?
  Current Opinion in Urology, February 11, 2022
• Combination Therapy in Widespread Prostate Metastatic Disease This case details the use of combination radioligand therapies in an elderly patient with advanced metastatic castrate-resistant prostate cancer.
  Applied Radiology, January 27, 2022
• PET/CT and Bone Scan in the Diagnosis of Prostate Lesions Is PET combined with CT and bone scan a more accurate means of detecting bone metastases of malignant prostate tumors?
  Translational Andrology and Urology, January 11, 2022
• Molecular Alterations and Immune Checkpoint Blockade Could certain genomic biomarkers predict response or resistance to immune checkpoint inhibitor treatment?
  Journal of the National Cancer Institute, January 11, 2022
• PSMA Targeted and Hormone Therapy in Renally Impaired Patient This case demonstrates that PSMA-PET therapy can be used safely in elderly patients with metastatic prostate cancer and in patients with renal impairment.
  Applied Radiology, January 06, 2022
• Treatments for Newly Diagnosed Metastatic Prostate Cancer This article provides an overview of new treatment approaches for metastatic hormone-sensitive prostate cancer.
  Translational Andrology and Urology, November 24, 2021
• Intensifying Prostate Cancer Screening in Black Men Could intensified PSA screening lead to earlier cancer detection and better outcomes among this high-risk population? A new study examines the benefits and risks of this strategy.
  Journal of the National Cancer Institute, November 15, 2021
• T2DM and Markers of Cutaneous Melanoma Aggressiveness This study investigated a possible relationship between type 2 diabetes mellitus and an increased incidence and/or aggressiveness of melanoma, with or without metformin therapy.
  The British Journal of Dermatology, November 10, 2021
• Epigenetics in Prostate Cancer: Clinical Implications Could epigenetics have a potential role in the diagnosis and management of prostate cancer?
  Translational Andrology and Urology, September 09, 2021
• Biomarkers for Detection of Prostate Cancer A new study explores the validity of five biomarkers for the detection of prostate cancer. Could these present an alternative to PSA screening?
  Translational Andrology and Urology, August 26, 2021
• LiSWT for the Treatment of Vasculogenic Erectile Dysfunction Could low intensity shock wave therapy offer another beneficial treatment option for men with vasculogenic erectile dysfunction?
  Translational Andrology and Urology, August 19, 2021